{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T23:47:36Z","timestamp":1782085656293,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Head and neck squamous cell carcinoma (HNSCC) is the most common malignancy of the head and neck region with relatively low survival rate and response and high resistance to treatment. Tongue and floor of the mouth are the most commonly involved sites. New therapies for oral squamous cell carcinoma (OSCC) treatment are still required. An attractive option for the treatment of OSCC is the use of photodynamic therapy (PDT). Considering metformin\u2019s potential to reduce cancer risk and inhibit proliferation, therefore the present study aims to evaluate its ability to potentiate the methylene blue-mediated photodynamic effect against the growth of tongue cancer cells in vitro and the possible molecular mechanisms of action involved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cytotoxic activity of metformin (MF) and\/or Methylene blue (MB)+laser light (L) against the growth of HNO97 tongue cells was determined using the sulforhodamine (SRB) method. Several protein expressions were determined using ELISA kits include mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), and caspase 8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Laser light at different energy per surface area induced inhibition in the surviving fraction of HNO97 cells, while in presence of MB (10\u00a0\u00b5g\/ml for 4\u00a0h.), the surviving fractions showed more inhibition. Addition of MF (1000\u00a0\u00b5g\/ml, for 24\u00a0h.) to MB\u2009+\u2009L induced significant 51 and 89% inhibition of cell survival at energy level of 45 and 337.5\u00a0J\/cm\n                      <jats:sup>2<\/jats:sup>\n                      , respectively. Addition of Metformin to MB-photodynamic therapy also increased the expression AMPK and decrease the expression of mTOR at the protein level. Moreover there were increase in Bax expression and decrease in Bcl2 expression with significant increase in caspase 8 expression at the protein level.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Such combined treatment showed promising synergistic interaction via several molecular pathways, which is well tolerated and readily applicable strategy to improve the therapeutic outcome of PDT in cancer cell treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00359-6","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T23:03:26Z","timestamp":1782083006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin enhances methylene blue-mediated photodynamic therapy in oral squamous cell carcinoma"],"prefix":"10.1186","volume":"38","author":[{"given":"Mohamed A.","family":"Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Sharaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Abdel-Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Safaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"4\u20135","key":"359_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","volume":"45","author":"S Warnakulasuriya","year":"2009","unstructured":"Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4\u20135):309\u201316.","journal-title":"Oral Oncol"},{"key":"359_CR2","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.4317\/medoral.24242","volume":"26","author":"AK Ferreira","year":"2021","unstructured":"Ferreira AK, Carvalho SH, Granville-Garcia AF, Sarmento DJ, Agripino GG, Abreu MH, Melo MC, Caldas AD Jr., Godoy GP. Survival and Prognostic Factors in Patients with Oral Squamous Cell Carcinoma. Med. Oral Patol. Oral Cir Bucal. 2021;26:e387\u201392.","journal-title":"Oral Cir Bucal"},{"issue":"1","key":"359_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/clm.1998.16.61","volume":"16","author":"UO Nseyo","year":"1998","unstructured":"Nseyo UO, Dougherty TJ, Potter W, Merrill D, et al. Photodynamic Therapy (PDT) in the Treatment of Patients with Resistant Superficial Bladder Cancer: A Long Term Experience. J Clin Laser Med Surg. 1998;16(1):67\u201375.","journal-title":"J Clin Laser Med Surg"},{"issue":"6","key":"359_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2012","unstructured":"Viollet B, Guiga B, Sanz Garacia N, Leclerc J, Frotetzm M, Andreelli F. Cellular and molecular mechanisms of metformin action. Clin Sci. 2012;122(6):253\u201370.","journal-title":"Clin Sci"},{"key":"359_CR5","doi-asserted-by":"crossref","unstructured":"Heckman-Stoddard BM, DeCensi A. Sahasrabuddhe V. V ., Ford L. G. Repurposing metformin for the prevention of cancer and cancer recurrence Diabetologia. 2017;60(9):1639\u20131647.","DOI":"10.1007\/s00125-017-4372-6"},{"key":"359_CR6","doi-asserted-by":"crossref","unstructured":"Nicol NI, Ma T. Activation of the AMPK Signaling and brain function: a Friend or Foe ournal of Neurochemistry. 2025;169:(11).e70283.","DOI":"10.1111\/jnc.70283"},{"key":"359_CR7","doi-asserted-by":"publisher","unstructured":"Song CW, Lee H, Dings RP, Williams B, Powers J, Santos TD, Choi BH, Park HJ. Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Sci Rep. 2012;2:362. https:\/\/doi.org\/10.1038\/srep00362. Epub 2012 Apr 12. PMID: 22500211; PMCID: PMC3324825.","DOI":"10.1038\/srep00362"},{"key":"359_CR8","doi-asserted-by":"publisher","first-page":"114981","DOI":"10.1016\/j.bcp.2022.114981","volume":"199","author":"X Sun","year":"2022","unstructured":"Sun X, Dong M, Gao YDY, et al. Metformin increases the radiosensitivity of non-small cell lung cancer cells by destabilizing NRF2. Biochem Pharmacol. 2022;199:114981.","journal-title":"Biochem Pharmacol"},{"key":"359_CR9","doi-asserted-by":"publisher","unstructured":"Sullivan LB, Chandel NS. Mitochondrial reactive oxygen species and cancer. Cancer Metab. 2014;2:17. https:\/\/doi.org\/10.1186\/2049-3002-2-17. PMID: 25671107; PMCID: PMC4323058.","DOI":"10.1186\/2049-3002-2-17"},{"key":"359_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay. J Natl Cancer Inst. 1990;82:1107\u201312.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"359_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.20114","volume":"61","author":"P Agostinis","year":"2011","unstructured":"Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: An update. CACancer J Clin. 2011;61(4):250\u201381.","journal-title":"CACancer J Clin"},{"issue":"2","key":"359_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4143\/crt.2005.37.2.122","volume":"37","author":"IA Kim","year":"2005","unstructured":"Kim IA, Kim JH, Shin JH, et al. TSA enhances radiosensitivity. Cancer Res Treat. 2005;37(2):122\u20138.","journal-title":"Cancer Res Treat"},{"key":"359_CR13","doi-asserted-by":"publisher","unstructured":"Franken NA, Oei AL, Kok HP, Rodermond HM, Sminia P, Crezee J, Stalpers LJ, Barendsen GW. Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review). Int J Oncol. 2013;42(5):1501\u201315. https:\/\/doi.org\/10.3892\/ijo.2013.1857. Epub 2013 Mar 13. PMID: 23503754.","DOI":"10.3892\/ijo.2013.1857"},{"key":"359_CR14","doi-asserted-by":"publisher","unstructured":"Subiel A, Ashmore R, Schettino G. Standards and methodologies for characterizing radiobiological impact of high-Z nanoparticles. Theranostics. 2016;6(10):1651\u201371. https:\/\/doi.org\/10.7150\/thno.15019\u00a0https:\/\/www.thno.org\/v06p1651.htm.","DOI":"10.7150\/thno.15019"},{"key":"359_CR15","first-page":"1","volume":"7","author":"Y Luo","year":"2025","unstructured":"Luo Y. Dose enhancement metrics for high-Z nanoparticles. Frontier Nanatechnol. 2025;7:1\u201316.","journal-title":"Frontier Nanatechnol"},{"key":"359_CR16","doi-asserted-by":"publisher","unstructured":"Ebrahimi G, Dalir E, Pouya AP, Bolhasani AJ, et al. Combination of metformin and laser against head and neck cancer cells in vitro. Open Dentistry J. 2023;17. https:\/\/doi.org\/10.2174\/0118742106276363231123071425.","DOI":"10.2174\/0118742106276363231123071425"},{"key":"359_CR17","doi-asserted-by":"publisher","unstructured":"Goel S, Singh R, Singh V, Singh H, Kumari P, Chopra H, Sharma R, Nepovimova E, Valis M, Kuca K, Emran TB. Metformin: activation of 5' AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action. Front Genet. 2022;13:1022739. https:\/\/doi.org\/10.3389\/fgene.2022.1022739. PMID: 36386794; PMCID: PMC9659887.","DOI":"10.3389\/fgene.2022.1022739"},{"key":"359_CR18","doi-asserted-by":"crossref","unstructured":"Srivastava P, Ahmad N, Gupta S, Mukhtar H. Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis: antisense Bcl-2 oligonucleotide sensitizes rif 1 cells to photodynamic therapy apoptosis. J Biol Chem. 2001;276(18):15481\u20138.","DOI":"10.1074\/jbc.M006920200"},{"key":"359_CR19","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.3390\/jcm14207258","volume":"14","author":"T Buset","year":"2025","unstructured":"Buset T, Yanni A, Gerbaux M, Bouland C, et al. Biological Anti-Tumoral Mechanisms of Metformin in Head and Neck Squamous Cell Carcinomas: A Systematic Review. J Clin Med. 2025;14:7258.","journal-title":"J Clin Med"},{"key":"359_CR20","first-page":"100215","volume":"6","author":"SN Raafat","year":"2023","unstructured":"Raafat SN, Sara Abd El Wahed SA, Badawi NM, Saber MM, Maha RA. Abdollah. .Enhancing the anticancer potential of metformin: fabrication of efficient nanospanlastics, in vitro cytotoxic studies on HEP-2 cells and reactome enhanced pathway analysisInternational. J Pharm. 2023;6:100215.","journal-title":"J Pharm"},{"key":"359_CR21","doi-asserted-by":"crossref","unstructured":"Kahalian S, Koopaie M, Hakimiha N, Kolahdooz S. Assessment of the methylene blue mediated photodynamic therapy on BCL2 and BAX genes expression at mRNA level and apoptosis of head and neck squamous cell carcinoma cell line Folia Medica. 2022;64(2):221\u20138.","DOI":"10.3897\/folmed.64.e60825"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00359-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T23:03:28Z","timestamp":1782083008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00359-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00359-6","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the in vitro study protocols and studies were approved by the Institutional Review Board of the National Cancer Institute, Cairo University, number SO2506-110-2005, and the National Institute of Laser Enhanced Science, Cairo University, number 25-6-17 (in).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}